Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 77.50
-1.70 (-2.15%)
Sep 4, 2026, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 428.75 million as of September 4, 2026. Its market cap has decreased by -12.23% in one year.
Market Cap
428.75M
Enterprise Value
368.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
77.50
ChartMarket Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 428.75M, an increase of 272.70%. That is a compound annual growth rate of 31.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 428.75M | 12.20% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 497.56M |
| Captor Therapeutics Spolka Akcyjna | 454.27M |
| Ryvu Therapeutics | 392.58M |
| BIOTON | 323.71M |
| Synthaverse | 222.39M |
| Molecure | 132.68M |
| Poltreg | 130.75M |
| Mabion | 124.77M |